Consult your pediatrician before using Zaditor (ketotifen fumarate ophthalmic solution) for a child. Zaditor is FDA-approved for adults and children 3 years and older for allergic conjunctivitis. Using it off-label for younger children or different conditions carries potential risks.
While some doctors might prescribe Zaditor off-label, this isn’t a standard practice. The lack of extensive pediatric studies for off-label uses means the safety and efficacy aren’t fully established. This is particularly crucial for infants and toddlers.
| Adverse Reactions | Younger children may experience increased sensitivity to side effects like burning, stinging, or eye irritation, potentially more intensely than older children or adults. |
| Dosage | Determining the correct dosage for off-label use is challenging and requires careful calculation. Incorrect dosage may be ineffective or even harmful. |
| Interactions | Interactions with other medications the child is taking are possible, potentially leading to unexpected effects. A thorough medication review is required. |
| Unforeseen Consequences | Long-term effects of off-label use in children are unknown. Potential long-term consequences are not fully understood. |
Always prioritize safety. Discuss alternative, age-appropriate treatments with your doctor before considering off-label Zaditor use for your child. They can offer informed recommendations based on your child’s specific needs and medical history. Open communication is key to making the best decisions for your child’s health.
